MDCO earnings call for the period ending March 31, 2019.
News & Analysis: The Medicines Company
MDCO earnings call for the period ending December 31, 2018.
Investors aren't happy about the drugmaker's latest capital raise.
These three biotech stocks are on a path to growth that relies on treating cholesterol with novel new drugs.
These biotech stocks jumped by 35% or more over the last few days. But can their momentum continue?
An analyst day is giving shares a boost.
It was a breakout year for the clinical-stage biotech.
Promising treatments could be on the way to address the diseases causing the most American deaths.
The Medicines Company is developing a new drug that could give Amgen's Repatha a run for its money in lowering bad cholesterol levels.
Shares of several biotech companies dropped after Amgen released important data from a long-term clinical trial that came up short of Wall Street's expectations.